share_log

復星國際:可能須予披露交易有關以吸收合併復宏漢霖之方式由復星新藥對復宏漢霖附前提條件私有化之建議

FOSUN INTL: POSSIBLE DISCLOSEABLE TRANSACTIONIN RELATION TOTHE PROPOSED PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS

HKEX ·  Jun 24, 2024 22:48
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more